Estrogen feedback is blocked centrally
Enclomiphene occupies estrogen receptors in the hypothalamus and pituitary. The brain reads circulating estrogen as lower than it is and stops suppressing gonadotropin release.
Treatment Profile
Enclomiphene
Enclomiphene citrate
Enclomiphene citrate is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator. It blocks estrogen feedback at the hypothalamus and pituitary, which raises luteinising hormone and follicle-stimulating hormone signalling, and in turn stimulates the testes to produce more of the body's own testosterone.
Medically reviewed by Dr. Adrian Vaux, MD
Board-certified, Internal Medicine · Men's Health
Last reviewed 3 August 2026Updated 9 August 2026
Treatment facts
- Drug class
- Selective Estrogen Receptor Modulator (SERM)
- Route
- Oral
- Common form
- Capsule / tablet
- Regulatory status
- Not FDA-approved for this use [NEEDS CITATION]
- Prescription status
- Prescription only
- Controlled substance
- No
Educational reference. Nothing on this page is a prescription, a diagnosis, or a promise of an individual result.
Section I
Enclomiphene Basics
What the drug is, how it is taken, and the facts a clinician establishes before prescribing it.
Clomiphene citrate is a mixture of two isomers: zuclomiphene and enclomiphene. Enclomiphene is the shorter-acting, more estrogen-antagonistic of the two. Isolating it is the reason it is discussed separately from clomiphene in the men's health literature — the zuclomiphene fraction accumulates over weeks and carries most of the estrogenic activity.
Because enclomiphene works upstream on the hypothalamic-pituitary-gonadal axis rather than supplying hormone from outside the body, testosterone produced under it is endogenous. That distinction is the central reason it appears in discussions of secondary hypogonadism in men who wish to preserve testicular function and fertility.
Enclomiphene is taken orally, typically once daily or on an alternating-day schedule, and is dosed by a clinician against baseline and follow-up laboratory values [NEEDS CITATION]. It is not an over-the-counter supplement and it is not appropriate for every man with low testosterone — primary testicular failure, for example, does not respond to upstream signalling.
At a glance
- Axis targeted
- Hypothalamic-pituitary-gonadal
- Hormone source
- Endogenous (own production)
- Typical monitoring
- Total & free testosterone, LH, FSH, estradiol, CBC
Section II
How Enclomiphene Works
The mechanism is a feedback loop correction, not a hormone replacement. Three steps, in order.
LH and FSH signalling rises
Gonadotropin-releasing hormone pulses increase, and the pituitary secretes more luteinising hormone and follicle-stimulating hormone [NEEDS CITATION].
The testes respond
Leydig cells increase testosterone synthesis under LH; Sertoli cells support spermatogenesis under FSH. Output is the body's own, which is why testicular volume and sperm parameters are generally maintained.
Response depends on an intact axis. Where the pituitary or testes cannot respond, upstream stimulation will not produce testosterone regardless of dose.
Section III
Enclomiphene Uses
These categories are kept separate on purpose. Approved, off-label, and studied are not the same claim.
Approved uses
United States, as of the review date above.- Enclomiphene citrate has no current FDA-approved indication as a single agent [NEEDS CITATION].
- Clomiphene citrate — the isomer mixture — is FDA-approved for ovulation induction in women, not for men [NEEDS CITATION].
Off-label clinical use
Prescribed at clinician discretion after evaluation.- Secondary hypogonadism in adult men with low testosterone and low or inappropriately normal LH/FSH.
- Men with low testosterone who wish to avoid suppression of endogenous production or preserve fertility.
- Post-cycle restoration of the axis after exogenous androgen exposure.
Studied / investigational
Reported in the literature; not a treatment recommendation.- Testosterone response versus topical testosterone in overweight men with secondary hypogonadism [NEEDS CITATION].
- Sperm concentration and semen parameters during treatment [NEEDS CITATION].
- Metabolic markers, including insulin sensitivity and lipids [NEEDS CITATION].
Section IV
Drug Category
Where enclomiphene sits pharmacologically, and which drugs it is most often confused with.
Selective Estrogen Receptor Modulator (SERM)
A selective estrogen receptor modulator binds estrogen receptors and acts as an antagonist in some tissues and an agonist in others. That tissue selectivity is the defining feature of the class: enclomiphene antagonises estrogen signalling in the hypothalamus and pituitary, which is where its effect on gonadotropins comes from.
Others in this class
- Clomiphene citrate
- Isomer mixture containing enclomiphene
- Tamoxifen
- SERM, primarily oncology use
- Raloxifene
- SERM, bone and breast tissue selectivity
Section V
Enclomiphene Side Effects
Reported in trials and prescribing information for enclomiphene and clomiphene. Frequency varies by study and population.
Commonly reported
- Headache
- Nausea
- Hot flashes or flushing
- Mood changes or irritability
- Fatigue
- Increased haematocrit
Less common or more serious considerations
- Visual disturbance, including blurred vision or floaters — reported with clomiphene and a reason to stop and seek review
- Elevated liver enzymes
- Thromboembolic events, reported rarely with SERMs
- Gynecomastia or breast tenderness
- Testicular discomfort
Any new visual symptom, chest pain, shortness of breath, or leg swelling warrants prompt clinical attention rather than a dose adjustment [NEEDS CITATION].
Section VI
Interactions & Contraindications
Conditions and co-prescriptions that change the risk calculation, and the ones that rule it out entirely.
Contraindications
- Known hypersensitivity to enclomiphene, clomiphene, or their excipients
- Active or prior hormone-sensitive malignancy without oncology clearance
- Uncontrolled liver disease
- History of thromboembolic disease without specialist review
- Primary testicular failure, where upstream stimulation cannot work
Relevant health conditions
- Erythrocytosis or baseline haematocrit above range
- Untreated obstructive sleep apnoea
- Depression or bipolar disorder — mood effects are reported
- Migraine with visual aura
Medication interactions
- Exogenous testosterone
- Suppresses the axis enclomiphene acts on; concurrent use requires a clear clinical rationale.
- Aromatase inhibitors
- Overlapping effect on estradiol; combined use can drive estradiol too low.
- hCG and gonadotropins
- Additive stimulation of testosterone production; monitor haematocrit and estradiol.
- Anticoagulants
- Reported interaction risk with SERMs; monitoring may be required [NEEDS CITATION].
This list is not exhaustive. Every medication, supplement, and prior hormone exposure should be disclosed to the prescribing clinician before starting.
Section VII
Warnings & Precautions
Labelled warnings and the monitoring that accompanies them during treatment.
Baseline and follow-up laboratory testing
Treatment decisions rest on morning total and free testosterone, LH, FSH, estradiol, and a complete blood count, repeated on schedule [NEEDS CITATION].
Visual symptoms
Blurred vision, spots, or flashes should prompt discontinuation and clinical review rather than continued dosing.
Fertility is not contraception
Preserved or improved sperm parameters mean fertility is possible during treatment. It is not a fertility treatment and it is not birth control.
Not for use in women or anyone under 18
This profile addresses adult men. Use outside that population is a separate clinical question.
Section VIII
What the Research Shows
Summaries of published work, kept plain. Numbers are reported as the authors reported them; nothing here predicts an individual outcome.
Testosterone levels
BJU International2016
Randomised comparison of enclomiphene citrate against topical testosterone in overweight men with secondary hypogonadism reported that both raised morning total testosterone into the normal range.
[NEEDS CITATION]
LH and FSH response
Journal of Clinical Endocrinology & Metabolism2014
Enclomiphene raised luteinising hormone and follicle-stimulating hormone, consistent with central estrogen-receptor antagonism, whereas exogenous testosterone lowered both.
[NEEDS CITATION]
Sperm concentration
Fertility and Sterility2015
Sperm concentration was maintained in men on enclomiphene over the treatment period, while the topical-testosterone comparator group showed reductions.
[NEEDS CITATION]
Comparison with exogenous testosterone
Translational Andrology and Urology2019
Reviews of oral SERM therapy versus testosterone replacement describe similar total-testosterone effects with preservation of gonadotropin signalling, and call for longer-duration trials.
[NEEDS CITATION]
Section X
Sources & References
Primary literature, prescribing information and clinical guidelines used to write this profile.
- 1.
Kim ED, et al. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone.
BJU International2016Primary research[NEEDS CITATION] - 2.
Wiehle RD, et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial.
Fertility and Sterility2014Primary research[NEEDS CITATION] - 3.
Clomiphene citrate — FDA prescribing information.
U.S. Food and Drug Administration[NEEDS CITATION]Prescribing information[NEEDS CITATION] - 4.
Endocrine Society clinical practice guideline: testosterone therapy in men with hypogonadism.
Journal of Clinical Endocrinology & Metabolism2018Clinical guideline[NEEDS CITATION] - 5.
American Urological Association guideline: evaluation and management of testosterone deficiency.
AUA2018Clinical guideline[NEEDS CITATION]
This profile is written for education, reviewed against primary literature and prescribing information, and updated on a fixed schedule. It is not a prescription, a diagnosis, or a promise of any individual result.
Considering enclomiphene as treatment?
Whether enclomiphene is appropriate depends on your bloodwork, your history, and a clinician's evaluation. Caesar begins with a 40+ marker panel and a physician reading it — not with a prescription.
Not live in preview
Section IX
Frequently Asked
The questions clinicians are asked most often, answered without hedging.
If enclomiphene is the right mechanism for your labs and goals, a physician can decide after reviewing your panel.
Not live in preview
Related reading
Comparison
Enclomiphene vs. TRT
Two routes to the same number, with different effects on the axis, fertility, and monitoring.
7 min readNot yet available
Fertility
Enclomiphene and Fertility
What the trials report about sperm concentration during treatment, and what they do not claim.
6 min readNot yet available
Timeline
How Long Does Enclomiphene Take to Work?
Hormonal changes appear before symptomatic ones. Why the lab schedule is set the way it is.
5 min readNot yet available
Editorial & Medical Notice
Caesar publishes educational reference material. It is not a diagnosis, a prescription, or a promise of an individual result. Treatment decisions belong to you and a licensed physician who has reviewed your history and laboratory work. Our content is written by our editorial team, cited to primary literature, reviewed by a licensed clinician, and re-reviewed on a fixed schedule.